Fulminant Type 1 Diabetes Mellitus With Concomitant Coxsackievirus B6 Antibody Elevation and RNA‐Based COVID‐19 Vaccination: A Case Report and Review of the Literature

Fulminant Type 1 Diabetes Mellitus With Concomitant Coxsackievirus B6 Antibody Elevation and RNA‐Based COVID‐19 Vaccination: A Case Report and Review of the Literature

ABSTRACT Fulminant type 1 diabetes is a rare but severe condition that can develop rapidly, often in association with viral infections. In this case, coxsackievirus B6 antibody levels were elevated after disease onset, though its significance remains unclear. This highlights the importance of thorou...

Full description

Saved in:
Bibliographic Details
Main Authors: Hisaka Minami, Shinya Furukawa, Teruki Miyake, Keisho Kurokawa, Yasuhiro Sasaki, Masayuki Nakaishi, Kensuke Nagamatsu, Hiroka Yamago, Naozumi Shibata, Yoichi Hiasa, Bunzo Matsuura
Format: Article
Language:English
Published: Wiley 2025-04-01
Series:Clinical Case Reports
Subjects:
autoimmune disease
COVID‐19
diabetes
type 1 diabetes
vaccine
Online Access:https://doi.org/10.1002/ccr3.70429
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:ABSTRACT Fulminant type 1 diabetes is a rare but severe condition that can develop rapidly, often in association with viral infections. In this case, coxsackievirus B6 antibody levels were elevated after disease onset, though its significance remains unclear. This highlights the importance of thorough viral screening in fulminant type 1 diabetes and the need for further research to better understand potential contributing factors, including in post‐vaccination contexts.
ISSN:2050-0904

Similar Items